Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Tvardi Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Tvardi Therapeutics Inc.
Rating: 1.93991675
Author: Trendlyne DVM scores

about

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

29.92 -0.36 (-1.19%)

268.47% Gain from 52W Low

14,257

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Tvardi Therapeutics Inc. is on 04 Sep 2025 for the purpose of Cantor Global Healthcare Conference See details

Not Eligible

Expensive Valuation

2.7 / 100

Technically Bullish

74.9 / 100

1Yr Price target upside is 91%

7 analysts

Tvardi Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

268.47% Gain from 52W Low

SWOT Analysis

Tvardi Therapeutics Inc. Live Price Chart